Solubilisierung stark lipophiler Arzneistoffe in lipidhaltige ...

Literaturverzeichnis
63. Larhed, A. W., The Mucus Layer and Other Barriers to Intestinal Drug Absorption, Diss., Faculty
of Pharmacy, Uppsala, Sweden, Almqvist & Wiksell International, Stockholm, Sweden, (1997).
64. Mizuno, M., Yoshida, M., Hashida, M., Kimura, T., und Sezaki, H., Effect of mucosal lipid
components on the membrane permeation of water -soluble drugs, Chem. Pharm. Bull. 33
(1985) 2932-2940.
65. Behrens, I., Stenberg, P., Artursson, P., und Kissel, T., The effect of mucus on the transepithelial
transport of lipophilic drugs in a mucus-producing cell line HT29-MTX, Proc. Int. Symp.
Controlled Release Bioact. Mater. 27 th (2000) 1218-1219.
66. MacAdam, A., The effect of gastro-intestinal mucus on drug absorption, Adv. Drug Deliv. Rev. 11
(1993) 201-220.
67. Nimmerfall, F. und Rosenthaler, J., Significance of the goblet-cell mucin layer, the outermost
luminal barrier to passage through the gut wall, Biochem. Biophys Res. Commun. 94 (1980)
960-966.
68. Smithson, K. W., Millar, D. B., Jacobs, L. R., und Gray, G. M., Intestinal diffusion barrier: unstirred
water layer or membrane surface mucous coat?, Science 214 (1981) 1241-1244.
69. Behrens, I., Stenberg, P., Artursson, P., und Kissel, T., Transport of lipophilic drug molecules in a
new mucus-secreting cell culture model based on HT29-MTX cells, Pharm. Res. 18 (2001) 1138-
1145.
70. Jackson, M. J., Drug transport across gastrointestinal epithelia, In: Johnson, L. R. [Hrsg.],
Physiology of the gastrointestinal tract (2 nd Edn.), Raven Press, NY, USA, (1987), S. 1795-1621.
71. Hidalgo, I. J., Hillgren, K. M., Grass, G. M., und Borchardt, R. T., Characterization of the unstirred
water layer in Caco-2 cell monolayers using a novel diffusion apparatus, Pharm. Res. 8 (1991)
222-227.
72. Larhed, A. W., Artursson, P., und Bjork, E., The influence of intestinal mucus components on the
diffusion of drugs., Pharm. Res. 15 (1998) 66-71.
73. LaMont, J. T., Mucus: the front line of intestinal mucosal defense, Ann. N. Y. Acad. Sci. 664
(1992) 190-201.
74. Bhat, P. G., Flanagan, D. R., und Donovan, M. D., The limiting role of mucus in drug absorption:
Drug permeation through mucus solution, Int. J. Pharm. 126 (1995) 179.
75. Mantle, M. und Thakore, E., Rabbit intestinal and colonic mucins: isolation, partial
characterization, and measurement of secretion using an enzyme-linked immunoassay, Biochem.
Cell Biol. 66 (1988) 1045-1054.
76. Champe, P. C. und Harvey, R. A., Biochemistry, (2 nd Edn.), Lippincott, Philadelphia, PA, USA,
(1994), S. 157-162.
77. Wiedmann, T. S., Herrington, H., Deye, C., und Kallick, D., Distribution and diffusion of sodium
taurocholate and egg phosphatidylcholine aggregates in rat intestinal mucin, Pharm. Res. 18
(2001) 1489-1496.
78. Lee, S. P. und Nicholls, J. F., Diffusion of charged ions in mucus gel: effect of net charge,
Biorheology 24 (1987) 565-569.
79. Karlsson, J., Wikman, A., und Artursson, P., The mucus layer as a barrier to drug absorption in
monolayers of human intestinal epithelial HT29-H goblet cells, Int. J. Pharm. 99 (1993) 209-218.
80. Jastrow, H., Glykokalix, Elektronenmikroskopischer Atlas im Internet, (2004), http://www.unimainz.de/FB/Medizin/Anatomie/workshop/EM/EMGlykokalix.html.
81. Nuhn, P., Transport proteins as drug targets. Biochemical principles of membrane transport,
Pharm. Ztg. 144 (1999) 541-544.
82. Tsuji, A. und Tamai, I., Carrier-mediated intestinal transport of drugs, Pharm. Res. 13 (1996) 963-
977.
83. Wacher, V. J., Wu, C. Y., und Benet, L. Z., Overlapping substrate specificities and tissue
distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity
in cancer chemotherapy, Mol. Carcinog. 13 (1995) 129-134.
cxii